Tag: symbol: NVS

Sunday, Exelixis Inc EXEL provided financial guidance for fiscal year 2024 and delivered an update on its business. The company announced preliminary FY23 revenue of $1.83 billion versus the consensus of $1.84 billion,…

The U.S. Food and Drug Administration has recently issued a stern warning to the public, advising against the purchase and use of multiple specific over-the-counter eye drop products from prominent brands.  The agency…

Stocks enjoyed a positive midday trading session in New York, with all major indices in the green. Additionally, nine out of 11 S&P 500 sectors posted gains. Traders are eagerly…